Home
About Us
- Team
- Careers
Product & Technology
Investors
News & Events
- Press
Contact

Paris

October 7, 2019

Therapixel runs against breast cancer

Therapixel ran ODYSSEA marathon to support the fight…

by Neliya Tumbeva

Text

Therapixel is one of the leading French software companies specialising in artificial intelligence applied to medical imaging.

LATEST BLOG NEWS

Therapixel announces launch of prospective study on the utility of Artificial Intelligence (AI) as part of second reading breast cancer screening mammograms October 19, 2022
Therapixel releases a new version of MammoScreen® that leverages prior exams for better accuracy May 14, 2022
Therapixel announces close of 15 M€ series B financing to deploy MammoScreen® 2D/3D May 12, 2022

RECOMMENDED POSTS

Therapixel announces launch of prospective study on the utility of Artificial Intelligence (AI) as part of second reading breast cancer screening mammograms
Therapixel releases a new version of MammoScreen® that leverages prior exams for better accuracy
Therapixel announces close of 15 M€ series B financing to deploy MammoScreen® 2D/3D
Therapixel receives FDA clearance for use of its AI-based breast cancer screening software MammoScreen® on Digital Breast Tomosynthesis
Therapixel will be showcasing MammoScreen™ at the virtual ECR 2021

© 2023 Therapixel | Web design by Domaine-Pack.fr

Privacy Preference Center

Privacy Preferences